Skip to main content

OMEGA HEALTHCARE INVESTORS INC

For the period ended Sep 30, 2024. Filed Oct 31, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Oct 31, 2024

OHI$48.70-0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows

Unaudited (in thousands)

​​​​​​​
​Nine Months Ended September 30,
​ · 2024 · 2023
Cash flows from operating activities · ​ · ​
Net income​$301,339​$192,274
Adjustment to reconcile net income to net cash provided by operating activities:​​​
Depreciation and amortization​226,036​244,008
Impairment on real estate properties​22,094​87,992
Provision for rental income​1,136​20,633
(Recovery) provision for credit losses​(14,763)​11,643
Amortization of deferred financing costs and loss on debt extinguishment​10,584​9,998
Accretion of direct financing leases​106​80
Stock-based compensation expense​27,498​26,306
Gain on assets sold – net​(11,282)​(69,956)
Amortization of acquired in-place leases – net​(2,337)​(8,911)
Straight-line rent and effective interest receivables​(29,298)​(31,414)
Interest paid-in-kind​​(9,043)​​(7,992)
(Income) loss from unconsolidated joint ventures​​(4,331)​​2,327
Change in operating assets and liabilities – net:​​​
Contractual receivables​1,429​(1,283)
Lease inducements​699​(11,970)
Other operating assets and liabilities​595​(10,979)
Net cash provided by operating activities​520,462​452,756
Cash flows from investing activities​​​​
Acquisition of real estate​(229,803)​(211,216)
Net proceeds from sale of real estate investments​68,757​261,288
Investments in construction in progress​(59,292)​(29,068)
Placement of loan principal​(272,889)​(242,627)
Collection of loan principal​113,552​135,963
Investments in unconsolidated joint ventures​​(398)​​(12,178)
Distributions from unconsolidated joint ventures in excess of earnings​2,835​3,016
Capital improvements to real estate investments​(22,278)​(23,305)
Proceeds from net investment hedges​8,429​—
Receipts from insurance proceeds​1,657​6,033
Net cash used in investing activities​(389,430)​(112,094)
Cash flows from financing activities​​
Proceeds from long-term borrowings​657,819​507,072
Payments of long-term borrowings​(1,142,788)​(507,250)
Payments of financing related costs​(6,903)​(3,333)
Net proceeds from issuance of common stock​801,223​327,744
Dividends paid​(503,998)​(479,301)
Net payments to noncontrolling members of consolidated joint venture​545​(202)
Proceeds from derivative instruments​​—​​92,577
Redemption of Omega OP Units​​—​​(77)
Distributions to Omega OP Unit Holders​(22,988)​(20,751)
Net cash used in financing activities​(217,090)​(83,521)
Effect of foreign currency translation on cash, cash equivalents and restricted cash​1,638​132
(Decrease) Increase in cash, cash equivalents and restricted cash​(84,420)​257,273
Cash, cash equivalents and restricted cash at beginning of period​444,730​300,644
Cash, cash equivalents and restricted cash at end of period​$360,310​$557,917
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.